Tirzepatide represents a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://brianldyh195344.frewwebs.com/39851195/tirzepatide-a-game-changer-for-type-2-diabetes